BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9197448)

  • 1. Intrauterine administration of levonorgestrel 5 and 10 microg/24 hours in perimenopausal hormone replacement therapy. A randomized clinical study during one year.
    Wollter-Svensson LO; Stadberg E; Andersson K; Mattsson LA; Odlind V; Persson I
    Acta Obstet Gynecol Scand; 1997 May; 76(5):449-54. PubMed ID: 9197448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response.
    Raudaskoski T; Tapanainen J; Tomás E; Luotola H; Pekonen F; Ronni-Sivula H; Timonen H; Riphagen F; Laatikainen T
    BJOG; 2002 Feb; 109(2):136-44. PubMed ID: 11888095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 5-year follow-up study on the use of a levonorgestrel intrauterine system in women receiving hormone replacement therapy.
    Varila E; Wahlström T; Rauramo I
    Fertil Steril; 2001 Nov; 76(5):969-73. PubMed ID: 11704119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrauterine levonorgestrel delivered by a frameless system, combined with systemic estrogen: acceptability and endometrial safety after 3 years of use in peri- and postmenopausal women.
    Wildemeersch D; Janssens D; Schacht E; Pylyser K; de Wever N
    Gynecol Endocrinol; 2005 Jun; 20(6):336-42. PubMed ID: 16019384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acceptability of a small intrauterine progestogen-releasing system for continuous combined hormone therapy in early postmenopausal women.
    Sturdee DW; Rantala ML; Colau JC; Zahradnik HP; Riphagen FE;
    Climacteric; 2004 Dec; 7(4):404-11. PubMed ID: 15799612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine or oral administration of levonorgestrel in combination with estradiol to perimenopausal women--effects on lipid metabolism during 12 months of treatment.
    Andersson K; Stadberg E; Mattsson LA; Rybo G; Samsioe G
    Int J Fertil Menopausal Stud; 1996; 41(5):476-83. PubMed ID: 8934257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the levonorgestrel-releasing intrauterine system plus estrogen therapy in perimenopausal and postmenopausal women: systematic review and meta-analysis.
    Somboonporn W; Panna S; Temtanakitpaisan T; Kaewrudee S; Soontrapa S
    Menopause; 2011 Oct; 18(10):1060-6. PubMed ID: 21720280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous combined parenteral estrogen substitution and intrauterine progestogen delivery: the ideal HST combination?
    Wildemeersch D; Janssens D; Weyers S
    Maturitas; 2005 Jun; 51(2):207-14. PubMed ID: 15917162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why perimenopausal women should consider to use a levonorgestrel intrauterine system.
    Wildemeersch D
    Gynecol Endocrinol; 2016 Aug; 32(8):659-661. PubMed ID: 26930021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial suppression with a new 'frameless' levonorgestrel releasing intrauterine system in perimenopausal and postmenopausal women: a pilot study.
    Wildemeersch D; Schacht E
    Maturitas; 2000 Jul; 36(1):63-8. PubMed ID: 10989243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levonorgestrel intrauterine system (LNG-IUS) with conjugated oral equine estrogen: a successful regimen for HRT in perimenopausal women.
    Hampton NR; Rees MC; Lowe DG; Rauramo I; Barlow D; Guillebaud J
    Hum Reprod; 2005 Sep; 20(9):2653-60. PubMed ID: 15905289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.
    Antoniou G; Kalogirou D; Karakitsos P; Antoniou D; Kalogirou O; Giannikos L
    Maturitas; 1997 Mar; 26(2):103-11. PubMed ID: 9089559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
    Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
    Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
    Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a transdermal continuous combined and an interrupted progestogen HRT.
    Cameron ST; Glasier AF; Gebbie A; Dewart H; Baird DT
    Maturitas; 2006 Jan; 53(1):19-26. PubMed ID: 16325020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The levonorgestrel-releasing intrauterine system for endometrial protection during estrogen replacement therapy: a clinical review.
    Depypere H; Inki P
    Climacteric; 2015; 18(4):470-82. PubMed ID: 25553775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and comfort of long-term continuous combined transdermal estrogen and intrauterine levonorgestrel administration for postmenopausal hormone substitution - a review.
    Wildemeersch D
    Gynecol Endocrinol; 2016 Aug; 32(8):598-601. PubMed ID: 27117308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrauterine release of levonorgestrel--a new way of adding progestogen in hormone replacement therapy.
    Andersson K; Mattsson LA; Rybo G; Stadberg E
    Obstet Gynecol; 1992 Jun; 79(6):963-7. PubMed ID: 1579323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.